Enzo, ABI Lose New Trial Bids After $49M DNA Patent Verdict

Law360, Los Angeles (August 02, 2013, 10:38 PM ET) -- A Connecticut federal judge Thursday denied plaintiffs' and defendants' requests for a new trial in a patent infringement dispute over whether Applied Biosystems Inc. infringed Enzo Biochem Inc.’s DNA sequencing systems, a fight that ended in a $48.6 million verdict for Enzo.

U.S. District Judge Janet Bond Arderton ruled against both parties’ posttrial motions for a new trial, ruling that Enzo deserved no more damages than it was awarded at trial for ABI’s alleged infringements. Further, the new evidence introduced by the defendants wasn’t sufficient to...
To view the full article, register now.